Somerset Trust’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.97M | Buy |
9,282
+44
| +0.5% | +$8.63K | 0.56% | 52 |
|
|
2026
Q1 | $1.81M | Buy |
9,238
+127
| +1% | +$24.7K | 0.56% | 53 |
|
|
2025
Q4 | $1.58M | Buy |
9,111
+29
| +0.3% | +$5.28K | 0.48% | 58 |
|
|
2025
Q3 | $1.73M | Sell |
9,082
-150
| -2% | -$26.6K | 0.53% | 54 |
|
|
2025
Q2 | $1.66M | Sell |
9,232
-128
| -1% | -$22.2K | 0.54% | 53 |
|
|
2025
Q1 | $1.58M | Sell |
9,360
-92
| -1% | -$15.1K | 0.56% | 49 |
|
|
2024
Q4 | $1.43M | Sell |
9,452
-16
| -0.2% | -$2.49K | 0.54% | 52 |
|
|
2024
Q3 | $1.47M | Sell |
9,468
-2
| -0% | -$299 | 0.55% | 51 |
|
|
2024
Q2 | $1.3M | Sell |
9,470
-48
| -0.5% | -$6.57K | 0.53% | 49 |
|
|
2024
Q1 | $1.27M | Sell |
9,518
-147
| -2% | -$19.1K | 0.52% | 50 |
|
|
2023
Q4 | $1.33M | Sell |
9,665
-250
| -3% | -$32.9K | 0.58% | 48 |
|
|
2023
Q3 | $1.21M | Sell |
9,915
-213
| -2% | -$28.4K | 0.55% | 47 |
|
|
2023
Q2 | $1.42M | Sell |
10,128
-796
| -7% | -$110K | 0.61% | 47 |
|
|
2023
Q1 | $1.55M | Sell |
10,924
-322
| -3% | -$46.1K | 0.67% | 47 |
|
|
2022
Q4 | $1.76M | Sell |
11,246
-33
| -0.3% | -$4.74K | 0.74% | 47 |
|
|
2022
Q3 | $1.38M | Sell |
11,279
-161
| -1% | -$21.2K | 0.64% | 47 |
|
|
2022
Q2 | $1.52M | Buy |
11,440
+1
| +0% | +$136 | 0.67% | 48 |
|
|
2022
Q1 | $1.57M | Sell |
11,439
-453
| -4% | -$63.1K | 0.61% | 52 |
|
|
2021
Q4 | $2.06M | Buy |
11,892
+16
| +0.1% | +$2.43K | 0.75% | 47 |
|
|
2021
Q3 | $1.73M | Sell |
11,876
-333
| -3% | -$48.7K | 0.7% | 51 |
|
|
2021
Q2 | $1.61M | Buy |
12,209
+2
| +0% | +$262 | 0.66% | 52 |
|
|
2021
Q1 | $1.57M | Sell |
12,207
-38
| -0.3% | -$4.68K | 0.68% | 52 |
|
|
2020
Q4 | $1.46M | Sell |
12,245
-62
| -0.5% | -$7.56K | 0.66% | 49 |
|
|
2020
Q3 | $1.41M | Sell |
12,307
-40
| -0.3% | -$4.73K | 0.71% | 48 |
|
|
2020
Q2 | $1.41M | Sell |
12,347
-23
| -0.2% | -$2.44K | 0.75% | 50 |
|
|
2020
Q1 | $993K | Sell |
12,370
-1,902
| -13% | -$197K | 0.65% | 51 |
|
|
2019
Q4 | $1.52M | Sell |
14,272
-246
| -2% | -$25.7K | 0.75% | 53 |
|
|
2019
Q3 | $1.55M | Sell |
14,518
-2,493
| -15% | -$256K | 0.82% | 51 |
|
|
2019
Q2 | $1.73M | Sell |
17,011
-242
| -1% | -$23.3K | 0.89% | 46 |
|
|
2019
Q1 | $1.55M | Hold |
17,253
| – | – | 0.82% | 49 |
|
|
2018
Q4 | $1.44M | Sell |
17,253
-251
| -1% | -$23.5K | 0.84% | 49 |
|
|
2018
Q3 | $1.89M | Sell |
17,504
-44
| -0.3% | -$4.83K | 0.93% | 41 |
|
|
2018
Q2 | $1.93M | Sell |
17,548
-1,166
| -6% | -$121K | 1.04% | 35 |
|
|
2018
Q1 | $1.88M | Sell |
18,714
-203
| -1% | -$20.8K | 0.97% | 38 |
|
|
2017
Q4 | $1.86M | Sell |
18,917
-5,620
| -23% | -$533K | 0.93% | 43 |
|
|
2017
Q3 | $2.3M | Sell |
24,537
-1,453
| -6% | -$154K | 1.22% | 21 |
|
|
2017
Q2 | $2.89M | Sell |
25,990
-222
| -0.8% | -$23.5K | 1.57% | 13 |
|
|
2017
Q1 | $2.57M | Sell |
26,212
-493
| -2% | -$47K | 1.44% | 16 |
|
|
2016
Q4 | $2.45M | Sell |
26,705
-779
| -3% | -$67.1K | 1.45% | 16 |
|
|
2016
Q3 | $2.33M | Sell |
27,484
-5,429
| -16% | -$456K | 1.39% | 16 |
|
|
2016
Q2 | $2.68M | Buy |
32,913
+5,504
| +20% | +$419K | 1.65% | 11 |
|
|
2016
Q1 | $1.96M | Sell |
27,409
-126
| -0.5% | -$8.45K | 1.3% | 16 |
|
|
2015
Q4 | $1.96M | Buy |
27,535
+7,465
| +37% | +$502K | 1.29% | 17 |
|
|
2015
Q3 | $1.23M | Buy |
20,070
+147
| +0.7% | +$10.3K | 0.87% | 38 |
|
|
2015
Q2 | $1.45M | Hold |
19,923
| – | – | 0.95% | 33 |
|
|
2015
Q1 | $1.53M | Buy |
+19,923
| New | +$1.43M | 1.01% | 28 |
|
Other funds holding DGX
EB
AAMU
JWM
P
SAM
OIAM
SFA
TFA
Somerset Trust's DGX Position: Q2 2026 in Review
Somerset Trust increased its Quest Diagnostics (DGX) stake by 0.48% in Q2 2026, buying an estimated $8.63K and bringing the position to 9,282 shares worth $1.97M. The position accounts for 0.56% of the portfolio, ranked #52.
Somerset Trust first reported a position in DGX in Q1 2015 and has held it in 46 quarters since. The position peaked at $2.89M in Q2 2017. 152 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- Somerset Trust held 9,282 shares of Quest Diagnostics worth $1.97M as of Q2 2026.
- Somerset Trust bought 44 Quest Diagnostics shares in Q2 2026, an estimated $8.63K.
- Quest Diagnostics made up 0.56% of Somerset Trust's portfolio in Q2 2026, its #52 holding.
- Somerset Trust first reported a position in Quest Diagnostics in Q1 2015 and has held it in 46 quarters since.
- Somerset Trust's Quest Diagnostics position peaked at $2.89M in Q2 2017.
- 152 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on Somerset Trust's 13F filing for Q2 2026, filed 6 Jul 2026.